Novartis Investigative Site

Dammam 40145

0 studies enrolling now · 5 studies all time

What they study most

Acute Heart Failure, Breast Cancer, Chronic Iron Overload Due to Transfusion-dependant Anemias, Chronic Kidney Disease (CKD), Diffuse Large B-cell Lymphoma, End Stage Renal Disease (ESRD), Hemodialysis, Renal Replacement Therapy, Renal Transplantation

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) — Completed
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy — Completed